About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Huntington's Disease Progression Tracked Using PET Scans By Feinstein Institute Researchers

by Rukmani Krishna on September 2, 2013 at 11:59 PM
Font : A-A+

 Huntington's Disease Progression Tracked Using PET Scans By Feinstein Institute Researchers

A new way to measure the progression of Huntington's disease, using positron emission tomography (PET) to scan the brains of carriers of the gene was discovered by investigators. The findings are published in the September issue of The Journal of Clinical Investigation.

Huntington's disease causes the progressive breakdown of nerve cells in the brain, which leads to impairments in movement, thinking and emotions. Most people with Huntington's disease develop signs and symptoms in their 40s or 50s, but the onset of disease may be earlier or later in life. Medications are available to help manage the symptoms of Huntington's disease, but treatments do not prevent the physical, mental and behavioral decline associated with the condition.

Advertisement

Huntington's disease is an inherited disease, passed from parent to child through a mutation in the normal gene. Each child of a parent with Huntington's disease has a 50/50 chance of inheriting the Huntington's disease gene, and a child who inherits the gene will eventually develop the disease. Genetic testing for Huntington's disease can be performed to determine whether a person carries the gene and is developing the disease even before symptoms appear. Having this ability provides an opportunity for scientists to study how the disease first develops and how it progresses in its early, presymptomatic stages. Even though a carrier of the Huntington's disease gene may not have experienced symptoms, changes in the brain have already taken place, which ultimately lead to severe disability. Brain imaging is one tool that could be used to track how quickly Huntington's disease progresses in gene carriers. Having a better way to track the disease at its earliest stages will make it easier to test drugs designed to delay or even prevent the onset of symptoms.

Researchers at the Feinstein Institute used PET scanning to map changes in brain metabolism in 12 people with the Huntington's disease gene who had not developed clinical signs of the illness. The researchers scanned the subjects repeatedly over a seven-year period and found a characteristic set (network) of abnormalities in their brains. The network was used to measure the rate of disease progression in the study participants. The Feinstein Institute investigators then confirmed the progression rate through independent measurements in scans from a separate group of Huntington's disease gene carriers who were studied in the Netherlands. The investigators believe that progression networks similar to the one identified in Huntington's disease carriers will have an important role in evaluating new drugs for degenerative brain disorders.
Advertisement

"Huntington's disease is an extremely debilitating disease. The findings make it possible to evaluate the effects of new drugs on disease progression before symptoms actually appear. This is a major advance in the field," said David Eidelberg, MD, Susan and Leonard Feinstein Professor and head of the Center for Neurosciences at the Feinstein Institute.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Health Benefits of Giloy
Breast Cancer Awareness Month 2021 - It's time to RISE
First-Ever Successful Pig-To-Human Kidney Transplantation
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Positron Emission Tomography Scan Single Photon Emission Computerized Tomography Huntington´s Disease 

Recommended Reading
Avicena to Advance Huntington's Disease Clinical Program into Phase III
Avicena Group, Inc.announced the selection of the optimal dose of HD-02, its novel drug candidate ....
Huntington´s Disease
Huntington’s disease is a genetic degenerative disorder that affects the brain and causes psychiatri...
Positron Emission Tomography Scan
PET scan helps in the diagnosis of conditions like cancer, heart disease and brain disorders. PET im...
Single Photon Emission Computerized Tomography
Single Photon Emission Computed Tomography, a nuclear imaging diagnostic tool helps in accurate asse...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use